Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Intervalo de año de publicación
1.
ACS Appl Mater Interfaces ; 14(45): 50499-50506, 2022 Nov 16.
Artículo en Inglés | MEDLINE | ID: mdl-36397312

RESUMEN

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by low-grade inflammation and insulin resistance. In this process, innate immune cells play a crucial role in recognizing the stimuli (free fatty acid, lipopolysaccharide, and cytokines) and mediating the inflammatory response, contributing to the development of T2DM. Neutralizing inflammatory cytokines and blocking the inflammation cascade provide great potential for the treatment of T2DM. Here, we applied a macrophage membrane as a bait, which could specifically recognize and bind the stimuli, to encapsulate nanoparticles and capture the stimuli, further preventing inflammation. The in vivo experiment results suggest that the nanoparticles could reduce the production of proinflammatory cytokines, decrease insulin resistance, and realize significant therapeutic effects for T2DM. A potential strategy is thus offered for blocking immune response, holding a wide application in metabolic and autoimmune diseases.


Asunto(s)
Diabetes Mellitus Tipo 2 , Resistencia a la Insulina , Nanopartículas , Humanos , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Diabetes Mellitus Tipo 2/prevención & control , Resistencia a la Insulina/fisiología , Macrófagos/metabolismo , Inflamación/metabolismo , Citocinas/metabolismo , Nanopartículas/uso terapéutico
3.
ACS Nano ; 15(12): 19468-19479, 2021 12 28.
Artículo en Inglés | MEDLINE | ID: mdl-34859990

RESUMEN

Nanomedicine-based photodynamic therapy (PDT) for melanoma treatment has attracted great attention. However, the complex design of polymer nanoparticles and high doses of photosensitizers used in intravenous injections (for sufficient accumulation of drugs in tumor lesions) pose a huge challenge to the commercialization and further clinical application. Herein, we fabricated the carrier-free nanoassemblies of a chlorin e6 (L-Ce6 NAs)-integrated fast-dissolving microneedles patch (L-Ce6 MNs) enriching only about 3 µg of Ce6 in the needle tips via a facile fabrication method. The L-Ce6 MNs had sufficient mechanical strength to penetrate the skin and facilitated the transportation of L-Ce6 NAs to a depth of 200-500 µm under the skin, thereby achieving efficient and accurate drug delivery to tumor lesions. In a xenograft mouse melanoma model, the L-Ce6 MNs-based PDT with low dose of Ce6 (0.12 mg/kg) exerted efficient ablation of the primary lesions in situ through reactive oxygen species (ROS) generation. More importantly, a significant abscopal effect was also elicited by activating immunogenic cell death (ICD) and releasing danger-associated molecular patterns (DAMPs), which in turn promoted dendritic cells (DCs) maturation and the subsequent antigen presentation, thereby facilitating the T-cell-mediated immune response without synergetic immunotherapies. Collectively, our findings indicate the facile, controllable, and fast-dissolving microneedles patch with a low dose of photosensitizers presented great therapeutic potential for enhanced photoimmunotherapy.


Asunto(s)
Melanoma , Nanopartículas , Fotoquimioterapia , Porfirinas , Animales , Línea Celular Tumoral , Melanoma/tratamiento farmacológico , Ratones , Fármacos Fotosensibilizantes/uso terapéutico , Porfirinas/uso terapéutico
4.
Chem Commun (Camb) ; 57(56): 6919-6922, 2021 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-34155490

RESUMEN

We demonstrate an intrinsic antitumor effect of polymer nanoparticles (P-NPs), which could re-program tumor-associated macrophages to pro-inflammatory phenotype. The intrinsic effect of P-NPs on macrophage repolarization and its combination with other therapies provide new ideas for drug delivery, macrophage regulation and immunotherapy in cancer treatment.


Asunto(s)
Antineoplásicos/farmacología , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Maleatos/farmacología , Nanopartículas/química , Poliestirenos/farmacología , Polivinilos/farmacología , Animales , Antineoplásicos/química , Antineoplásicos/toxicidad , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Maleatos/química , Maleatos/toxicidad , Ratones , Nanopartículas/toxicidad , Poliestirenos/química , Poliestirenos/toxicidad , Polivinilos/química , Polivinilos/toxicidad
5.
Eur J Pharmacol ; 881: 173197, 2020 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-32439260

RESUMEN

Alopecia is resulted from various factors that can decrease the regeneration capability of hair follicles and affect hair cycles. This process can be devastating physically and psychologically. Nevertheless, the available treatment strategies are limited, and the therapeutic outcomes are not satisfactory. According to the possible pathogenesis of nonscarring alopecia, especially androgenetic alopecia, recovering or replenishing the signals responsible for hair follicle stem cells activation is a promising strategy for hair regeneration. Recently, stem cell-based therapies, especially those based on the stem cell-derived conditioned medium (CM), which is secreted by stem cells and is rich in paracrine factors, have been widely explored as the hair regenerative medicine. Several studies have focused on altering the composition and up-regulating the amount of secretome of the stem cells, thereby enhancing its therapeutic effects. Besides, stem cell-derived exosomes, which are present in the CM as message entities, are also promising for hair regrowth. In this review, the up-to-date progress of research efforts focused on stem cell-based therapies for hair regeneration will be discussed, including their therapeutic potentials with respective merits and demerits, as well as the possible mechanisms.


Asunto(s)
Alopecia/cirugía , Medios de Cultivo Condicionados/metabolismo , Exosomas/trasplante , Folículo Piloso/crecimiento & desarrollo , Comunicación Paracrina , Regeneración , Trasplante de Células Madre , Células Madre/metabolismo , Alopecia/metabolismo , Alopecia/fisiopatología , Animales , Exosomas/metabolismo , Folículo Piloso/metabolismo , Humanos , Resultado del Tratamiento
6.
Biomaterials ; 189: 60-68, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30388590

RESUMEN

Endotoxemia is a severe pathophysiology induced by bacterial endotoxin (also known as lipopolysaccharide, LPS), causing high mortality in clinic due to the life-threatening syndromes, such as sepsis, shock, and multiple organ dysfunction. Removing or neutralizing endotoxin from the circulatory system has been proven to be a potential strategy for the treatment of endotoxemia. However, the selectivity and removal efficiency of existing detoxification approaches are not satisfied. Considering the crucial role of immune cells in LPS recognition and inflammation mediation, we design a disguised nanoparticle using macrophage membranes as bait to specifically capture and deactivate LPS. The in vivo experiment results demonstrate that the nanoparticles markedly weaken the immune response, reduce the inflammatory reaction, and improve the survival rate of endotoxic mice. These deceptive nanoparticles should be broadly applicable for treating a variety of diseases related to LPS, such as metabolic and vascular abnormalities in obesity, and diabetes-related diseases.


Asunto(s)
Membrana Celular/química , Endotoxemia/prevención & control , Lipopolisacáridos/aislamiento & purificación , Macrófagos/química , Nanopartículas de Magnetita/uso terapéutico , Animales , Membrana Celular/inmunología , Endotoxemia/inmunología , Lipopolisacáridos/inmunología , Macrófagos/inmunología , Nanopartículas de Magnetita/química , Masculino , Ratones , Ratones Endogámicos ICR , Células RAW 264.7
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA